BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee KA, Thomas AM, Bolte LA, Björk JR, de Ruijter LK, Armanini F, Asnicar F, Blanco-Miguez A, Board R, Calbet-Llopart N, Derosa L, Dhomen N, Brooks K, Harland M, Harries M, Leeming ER, Lorigan P, Manghi P, Marais R, Newton-Bishop J, Nezi L, Pinto F, Potrony M, Puig S, Serra-Bellver P, Shaw HM, Tamburini S, Valpione S, Vijay A, Waldron L, Zitvogel L, Zolfo M, de Vries EGE, Nathan P, Fehrmann RSN, Bataille V, Hospers GAP, Spector TD, Weersma RK, Segata N. Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma. Nat Med 2022;28:535-44. [PMID: 35228751 DOI: 10.1038/s41591-022-01695-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sia J, Neeson PJ, Haynes NM. Basic cancer immunology for radiation oncologists. J Med Imaging Radiat Oncol 2022. [PMID: 35352493 DOI: 10.1111/1754-9485.13406] [Reference Citation Analysis]
2 Hone Lopez S, Jalving M, Fehrmann RS, Nagengast WB, de Vries EG, de Haan JJ. The gut wall’s potential as a partner for precision oncology in immune checkpoint treatment. Cancer Treatment Reviews 2022;107:102406. [DOI: 10.1016/j.ctrv.2022.102406] [Reference Citation Analysis]
3 Fan JY, Huang Y, Li Y, Muluh TA, Fu SZ, Wu JB. Bacteria in cancer therapy: A new generation of weapons. Cancer Med 2022. [PMID: 35522104 DOI: 10.1002/cam4.4799] [Reference Citation Analysis]
4 Bhutiani N, Wargo JA. Gut microbes as biomarkers of ICI response - sharpening the focus. Nat Rev Clin Oncol 2022. [PMID: 35449306 DOI: 10.1038/s41571-022-00634-0] [Reference Citation Analysis]